| Structure |
Chemical Name |
CAS |
MF |
 |
Oseltamivir Impurity Mixture (MW:486 Da) |
|
|
|
|
2,2'-(7-((2R,3S)-1,3,4-trihydroxybutan-2-yl)-10-((2S,3R)-1,3,4-trihydroxybutan-2-yl)-1,4,7,10-tetraazacyclododecane-1,4-diyl)diacetic acid Gd3+ |
|
|
 |
(R)-Ethyl 3-(bromomethyl)hexanoate |
1956435-91-8 |
C9H17BrO2 |
|
|
Flucloxacillin Sodium EP Impurity B |
|
|
 |
4-PYRIDIN-4-YL-BUTYRIC ACID |
102878-73-9 |
C9H11NO2 |
|
|
1-Ethyl-2-[[(2-methoxy-5-sulphamoyl |
|
|
 |
2-(4-Bromo-3-formylphenoxy)-benzonitrile |
1160182-46-6 |
C14H8BrNO2 |
|
|
Carbetocin S-Oxide I |
|
|
|
|
Dolutegravir Impurity 15 |
|
|
![5'-(2-cyanophenyl)-6'-oxo-1'-phenyl-1',6'-dihydro-[2,3'-bipyridine] 1-oxide](/CAS/20210111/GIF/380919-67-5.gif) |
5'-(2-cyanophenyl)-6'-oxo-1'-phenyl-1',6'-dihydro-[2,3'-bipyridine] 1-oxide |
380919-67-5 |
C23H15N3O2 |
|
|
Empagliflozin Impurity 86 |
|
|
 |
Olopatadine Impurity 11 HBr |
4174-84-9 |
C21H24Br2NP |
|
|
Iohexol Impurity P |
|
|
 |
Sulbactam Impurity 2 |
111790-24-0 |
C8H13NO6S |
 |
Vortioxetine Impurity 8 HCl |
2137722-14-4 |
C18H23ClN2S |
|
|
Relugolix Impurity 1 |
3009131-53-4 |
|
 |
Oseltamivir Diastereomer III HCl |
2413185-95-0 |
C16H28N2O4 |
 |
Rocuronium bromide impurity (3,16,17-triol) |
|
C23H39NO4 |
 |
4-(4-amino-3-chlorophenoxy)-7-methoxyquinoline-6-carboxylic acid |
|
C17H13ClN2O4 |
|
|
Ornidazole Impurity 26 |
|
|
|
|
Pitavastatin Impurity 73 |
|
|
|
|
Furosemide Impurity 24 |
|
|
|
|
Brivaracetam Impurity 34 |
|
|
|
|
1-((2R,3R)-3-(4-(4-cyanophenyl)thiazol-2-yl)-2-(2,5-difluorophenyl)-2-hydroxybutyl)-4-(1-(((3-(hydroxymethyl)pyridin-2-yl)(methyl)carbamoyl)oxy)ethyl)-1H-1,2,4-triazol-4-ium chloride |
|
|
 |
1H-1,2,4-Triazole-1-propanol, α-(2,4-difluorophenyl)-α-(1H-1,2,4-triazol-1-ylmethyl)- |
1222655-38-0 |
C14H14F2N6O |
![IMp. C (EP): (4-(DiphenylMethyl)-1,1-bis[(E)-3-phenylprop-2-enyl]piperaziniuM Chloride](/CAS/20211123/GIF/95062-18-3.gif) |
IMp. C (EP): (4-(DiphenylMethyl)-1,1-bis[(E)-3-phenylprop-2-enyl]piperaziniuM Chloride |
95062-18-3 |
C35H35ClF2N2 |
|
|
IMp. E (EP): 4-AMino-5-(ethylsulphonyl)-2-Methoxybenzoic Acid |
|
|
 |
1-ニトロ-3,7-ジメチルアダマンタン |
6588-68-7 |
C12H19NO2 |
 |
6-O-Benzyl-4-dehydroxy-4-diMethylphenylsilyl Entecavir |
649761-24-0 |
C27H31N5O2Si |
 |
Desisobutyl-n-butyl BortezoMib |
1104011-35-9 |
C19H25BN4O4 |
 |
2-aMino-4-Methoxy-5-(3-Morpholinopropoxy)benzaMide |
246512-44-7 |
C15H23N3O4 |
 |
N-(4,6-dichloro-2-(propylthio)pyriMidin-5-yl)forMaMide |
1402150-28-0 |
C8H9Cl2N3OS |
 |
Ebastine IMpurity G |
1429071-65-7 |
C32H39NO3 |
 |
((R)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxaMido)propanaMido)butyl)boronic acid |
1132709-15-9 |
C19H25BN4O4 |
![N-[(1S)-2-アミノ-2-オキソ-1-(フェニルメチル)エチル]-2-ピラジンカルボキサミド](/CAS/GIF/289472-80-6.gif) |
N-[(1S)-2-アミノ-2-オキソ-1-(フェニルメチル)エチル]-2-ピラジンカルボキサミド |
289472-80-6 |
C14H14N4O2 |
 |
(3aS,4R,6S,6aR)-6-AMinotetrahydro-2,2-diMethyl-4H-cyclopenta-1,3-dioxol-4-ol |
592533-90-9 |
C8H15NO3 |
![(1R,2R,3S,5R)-3-(7-((1S,2R)-2-(3,4-difluorophenyl)cyclopropylaMino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol](/CAS/20150408/GIF/CB62664138.gif) |
(1R,2R,3S,5R)-3-(7-((1S,2R)-2-(3,4-difluorophenyl)cyclopropylaMino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
2096989-55-6 |
C23H28F2N6O4S |
 |
Rivaroxaban iMpurity |
1616563-62-2 |
C15H17N3O5 |
|
|
cefoxitin iMpurity D |
|
|
 |
3-Morpholinone, 4-(2,4-diaMinophenyl)- |
482308-13-4 |
C10H13N3O2 |
|
|
Tofacitinib Impurity H |
|
|
 |
3',6'-Dehydroclindamycin |
1440605-51-5 |
C18H31ClN2O5S |
|
|
Cefradine Impurity F |
|
|
 |
Mirabegron Impurity |
1684452-83-2 |
C26H28N6O3S2 |
 |
1-メチル-1H-インドール-6-オール |
130570-60-4 |
C9H9NO |
 |
2-(2-ヒドロキシフェニル)-4-メチルチアゾール-5-カルボン酸エチル |
118485-48-6 |
C13H13NO3S |
 |
32-Carboxycyanocobalamin |
121483-62-3 |
C63H87CoN13O15P |
|
|
Alvimopan Impurity 6 |
|
|
|
|
Sofosbuvir Impurity28 |
|
|
|
|
Rivaroxaban Impurity 10 |
|
|
|
|
Ipragliflozin Impurity 1 |
|
|
 |
(17α)-4-Bromo-17-hydroxy-3-oxo-19-norpregna-4,9-diene-21-nitrile |
98149-13-4 |
C20H24BrNO2 |
 |
316173-27-0 |
316173-27-0 |
C17H28N2O5 |
 |
Irbesartan Impurity 7 |
|
C25H28N6O |
 |
Guanosine |
30747-23-0 |
C18H21N5O9 |
|
|
Minoxidil Impurity G |
|
|
|
|
Brivaracet amoxidation Impurity 2 |
|
|
|
|
Sugammadex Impurity U |
|
|
|
|
3-(6'-oxo-1'-phenyl-1',6'-dihydro-[2,3'-bipyridin]-5'-yl)-[1,1'-biphenyl]-2,2'-dicarbonitrile |
|
|
|
|
Cefmetazole Sodium Impurity B |
|
|
|
|
(3R,5S,E)-tert-butyl 7-(4-(3-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoate |
|
|
 |
1-Piperazinebutanol, 4-(1,2-benzisothiazol-3-yl)- |
159729-16-5 |
C15H21N3OS |
 |
1,4-Piperazinedibutanol |
92036-96-9 |
C12H26N2O2 |
![1H-Benz[de]isoquinolin-1-one, 2-(3S)-1-azabicyclo[2.2.2]oct-3-yl-2,3,3a,4,5,6-hexahydro-6-hydroxy-, (3aS)-](/CAS/20210305/GIF/2446343-19-5.gif) |
1H-Benz[de]isoquinolin-1-one, 2-(3S)-1-azabicyclo[2.2.2]oct-3-yl-2,3,3a,4,5,6-hexahydro-6-hydroxy-, (3aS)- |
2446343-19-5 |
C19H24N2O2 |
|
|
2-yl)oxy)-6,8,11-trihydroxy-8-(((2S,3S,4S,6R)-3-hydroxy-2-methyl-6-(((1S,3S)-3,5,12-trihydroxy-3-(2-hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11- |
|
|
|
|
Oxacillin Impurity IMPA |
|
|
|
|
Rebamipide Impurity X(Rebamipide Impurity 7) |
|
|
|
|
(1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(3-fluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
|
|
|
|
sodium 1-(5-hydroxy-3-methyl-1-phenyl-1H-pyrazol-4-yl)ethane-1-sulfonate |
|
|
 |
Pyrimidine, 4,6-dichloro-5-nitroso-2-(propylthio)- |
2512210-19-2 |
C7H7Cl2N3OS |
 |
5-Pyrimidinamine, 4,6-dichloro-N-hydroxy-2-(propylthio)- |
2517939-84-1 |
C7H9Cl2N3OS |
 |
(R)-4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)benzenediazonium tetrafluoroborate |
1630761-21-5 |
C11H11N4O+ |
|
|
8-chloro-11-(1-((5-methylpyridin-3-yl)methyl)piperidin-4-ylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine 1-oxide |
|
|
![ボセンタン関連化合物B (4-(TERT-ブチル)-N-[6-ヒドロキシ-5-(2-メトキシフェノキシ)-(2,2'-ビピリミジン)-4-イル]ベンゼンスルホンアミド)](/CAS/20150408/GIF/174227-14-6.gif) |
ボセンタン関連化合物B (4-(TERT-ブチル)-N-[6-ヒドロキシ-5-(2-メトキシフェノキシ)-(2,2'-ビピリミジン)-4-イル]ベンゼンスルホンアミド) |
174227-14-6 |
C25H25N5O5S |
![BenzaMide, N-[1-(3,5-di-O-benzoyl-2-C-Methyl-β-D-arabinofuranosyl)-1,2-dihydro-2-oxo-4-pyriMidinyl]-](/CAS/20180808/GIF/863329-62-8.gif) |
BenzaMide, N-[1-(3,5-di-O-benzoyl-2-C-Methyl-β-D-arabinofuranosyl)-1,2-dihydro-2-oxo-4-pyriMidinyl]- |
863329-62-8 |
C31H27N3O8 |
|
|
Fosfluconazole iMpurity |
|
|
 |
Cinacalcet Impurity D |
1271930-15-4 |
C32H31F6N |
 |
BendaMustine Dihydroxy IMpurity |
109882-29-3 |
C16H24ClN3O4 |
 |
BroMocriptine IMpurity G |
|
C32H40BrN5O5 |
 |
Captopril IMpurity H |
205521-07-9 |
C15H23NO5S2 |
 |
Cefdinir IMpurity 3 (Cefdinir Decarboxy Open Ring Lactone (Mixture of A and B)) |
178949-04-7 |
C13H15N5O4S2 |
|
|
Voriconazole Impurity 2 |
|
|
|
|
Safinamide Impurity 1 |
|
|
|
|
Caspofungin impurit 2 |
|
|
|
|
Lamivudine impurity 1 |
|
|
 |
Raltitrexed Impurity 1 |
1378372-01-0 |
C10H10N2O2 |
 |
Loratadine Impurity 6 |
|
C22H23ClN2O2 |
|
|
Mirabegron Impurity 3 |
|
|
|
|
Plerixafor Impurity C |
|
|
|
|
Vonoprazan Impuirty 8 |
|
|
|
|
Oseltamivir Impurity 94 |
|
|
|
|
Oseltamivir Impurity 82 |
|
|
|
|
Oseltamivir Impurity 74 |
|
|
 |
Uridine, 5'-(2-methylpropanoate) (9CI) |
886538-48-3 |
C13H18N2O7 |
|
|
Dapagliflozin Impurity 47 |
|
|
|
|
Crisaborole Impurity 17 |
|
|
|
|
Crisaborole Impurity 19 |
|
|
![1,5-Pentanedione, 1-(2-fluorophenyl)-5-[(4S)-2-oxo-4-phenyl-3-oxazolidinyl]-](/CAS/20210305/GIF/2514695-40-8.gif) |
1,5-Pentanedione, 1-(2-fluorophenyl)-5-[(4S)-2-oxo-4-phenyl-3-oxazolidinyl]- |
2514695-40-8 |
C20H18FNO4 |
 |
4-エトキシ-3-(4-ピリジニル)-3-ブテン-2-オン |
88349-61-5 |
C11H13NO2 |
 |
2,3-ジヒドロ-4-メチル-1H-1,5-ベンゾジアゼピン-2-オン |
6276-48-8 |
C10H10N2O |